Covance Not Cooling...
Health Care: Drugs
Valeant Pharmaceuticals International Inc (VRX: NYSE)
$78.17 2.42 | 3.19%
05/17/13 - 04:05 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 78.17 |
| 52 Week High | 78.37 |
| 52 Week Low | 42.47 |
| Avg. Daily Vol. (Mil) | 1.41 |
| Beta (3 year) | 1.03 |
| Share Related Items | |
| Mkt Cap (Mil) | 23,909.44 |
| Shares Out (Mil) | 305.86 |
| Float (Mil) | 217.94 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 2.88 |
| Total Debt / Equity | 2.96 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 6.36 |
| Price/Book | 6.67 |
| Price/Cash Flow | 23.20 |
| Per Share Data | |
| Earnings | -0.43 |
| Sales | 12.29 |
| Book Value | 11.73 |
| Cash Flow | 3.37 |
| Business Summary | |
|---|---|
| Valeant Pharmaceuticals International Inc is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. | |
| General Information | |
| 4787 Levy Street
Montreal, ON H4R 2P9 |
|
| www.valeant.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 7000 | |
| CEO: J. Michael Pearson | |
| Short Interest | |
| Current Month (Mil) | 4.83 |
| Previous Month (Mil) | 6.02 |
| Short Interest Ratio (Days) | 3.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -0.70 |
| Return on Investments | -0.90 |
| Profitability | |
| Gross Margin | 75.50 |
| EBIT Margin | 2.40 |
| Profit Margin | -3.50 |
Portfolios with VRX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ProRuane Cunniff
- ContributorStocks With Big Insider Buy...
- UserRetirement stocks
- ProPrivate Capital Management
- ProViking Global Investors
- UserWatch
- ContributorStocks With Big Insider Buy...
- Contributor12 Top Health Care Picks fo...
- ContributorStocks With Big Insider Buy...
Latest VRX Headlines from TheStreet
- 5 Stocks Pulling The Drugs Industry Downward 04.12.13 | 01:04 pm
- The Five Dumbest Things on Wall Street: April 12
04.12.13 | 05:04 am - Merz Withdrawal Frees Obagi-Valeant Merger 04.09.13 | 01:04 pm
- Valeant Pharmaceuticals International Stock Falls On Unusually High Volume (VRX) 04.03.13 | 03:04 pm
- 4 Stocks Raising The Health Care Sector Higher 04.01.13 | 01:04 pm
- Valeant Pharmaceuticals International Stock Hits New 52-Week High (VRX) 03.28.13 | 04:03 pm
- Valeant Buys Obagi Medical for $360 Million 03.20.13 | 08:03 am
- Health Care Stocks On The Rise With Help From 5 Stocks 03.19.13 | 01:03 pm
- Valeant Pharmaceuticals International Reaches New 52-Week High (VRX) 03.19.13 | 10:03 am
- Valeant Pharmaceuticals International Reaches New 52-Week High (VRX) 03.11.13 | 10:03 am
Press Releases for VRX
- Valeant Pharmaceuticals To Announce 2013 First Quarter Results On May 2, 2013 - PR Newswire 04.16.13 | 08:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Merz Pharma Group Withdraws Proposal To Acquire Obagi Medical Products - PR Newswire 04.08.13 | 07:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Valeant Pharmaceuticals Provides Update To Recent Event - PR Newswire 04.04.13 | 08:04 am
- Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash - PR Newswire 04.03.13 | 08:04 am
- Valeant Pharmaceuticals Announces Private Exchange Offer - PR Newswire 03.29.13 | 05:03 pm
- Rigrodsky & Long, P.A. Announces Investigation Of Obagi Medical Products, Inc. Buyout - PR Newswire 03.27.13 | 01:03 pm
Partner Headlines for VRX
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- IBD Big Cap 20 Analysis: Some Stocks Show Resilience - Investor's Business Daily 04.08.13 | 06:04 pm
- How The IBD 50 Can Help Investors Find Winning Stocks - Investor's Business Daily 04.05.13 | 04:04 pm
- AbbVie Offers Nice Dividend Yield, Stock At New High - Investor's Business Daily 04.01.13 | 05:04 pm
- Stocks Fall On Weak Data; Sinclair Broadcast Off High - Investor's Business Daily 04.01.13 | 01:04 pm
- Stocks Pop, But Declining Volume Dims Day's Gains - Investor's Business Daily 03.20.13 | 05:03 pm
- Stock Averages Move Up But Volume Can't Keep Pace - Investor's Business Daily 03.20.13 | 04:03 pm
- Stocks Up Ahead Of Fed Statement; Lennar At New High - Investor's Business Daily 03.20.13 | 01:03 pm
- Stocks Hold Up, Trade Mixed; Valeant, Obagi Lifted - Investor's Business Daily 03.20.13 | 12:03 pm
- Stocks End Mixed As Cyprus Rattles Investors; Ocwen dives - Investor's Business Daily 03.19.13 | 04:03 pm
